ArrowMark Colorado Holdings’s NexImmune, Inc. Common Stock NEXI Stock Holding History

ArrowMark Colorado Holdings’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-437	Closed	-$2.66K	–	330
2022 Q4	$2.66K	Sell	437 -38,324	-99%	-$478K	﹤0.01%	303
2022 Q3	$537K	Sell	38,761 -14,281	-27%	-$419K	0.01%	285
2022 Q2	$2.13M	Hold	53,042	–	–	0.02%	249
2022 Q1	$5.58M	Sell	53,042 -19,087	-26%	-$1.4M	0.05%	235
2021 Q4	$8.31M	Sell	72,129 -6,224	-8%	-$1.5M	0.07%	211
2021 Q3	$29.7M	Sell	78,353 -23,567	-23%	-$7.9M	0.23%	107
2021 Q2	$2.13M	Sell	101,920 -1,785	-2%	-$822K	0.02%	270
2021 Q1	$49.5M	Buy	+103,705	New	+$56.4M	0.37%	76

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

ArrowMark Colorado Holdings's NEXI Position: Q1 2023 in Review

ArrowMark Colorado Holdings sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2023, closing a stake of 437 shares — an estimated $2.66K sold.

ArrowMark Colorado Holdings first reported a position in NEXI in Q1 2021 and held it in 8 quarters. The position peaked at $49.5M in Q1 2021. 31 funds tracked by Wall St. Rank hold NEXI as of Q1 2023.

ArrowMark Colorado Holdings reported no remaining NexImmune, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
ArrowMark Colorado Holdings sold 437 NexImmune, Inc. Common Stock shares in Q1 2023, an estimated $2.66K.
ArrowMark Colorado Holdings first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
ArrowMark Colorado Holdings's NexImmune, Inc. Common Stock position peaked at $49.5M in Q1 2021.
31 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2023.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2023, filed 15 May 2023.